Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 08/12/2022 | VANGUARD GROUP INC | 683,896 | $217,000 | 0.00% | 1.61% |
| 08/12/2022 | GEODE CAPITAL MANAGEMENT, LLC | 187,066 | $59,000 | 11.46% | 0.44% |
| 08/12/2022 | SNOWDEN CAPITAL ADVISORS LLC | 110,000 | $34,000 | 0.00% | 0.26% |
| 08/15/2022 | BANK OF NEW YORK MELLON CORP | 86,016 | $27,000 | -0.68% | 0.20% |
| 08/15/2022 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 80,080 | $25,000 | 632.53% | 0.19% |
| 08/09/2022 | VIRTU FINANCIAL LLC | 63,193 | $20,000 | 165.51% | 0.15% |
| 08/12/2022 | NORTHERN TRUST CORP | 62,521 | $20,000 | 0.00% | 0.15% |
| 08/10/2022 | UBS GROUP AG | 48,961 | $16,000 | 167.80% | 0.12% |
| 08/10/2022 | HIGHTOWER ADVISORS, LLC | 44,000 | $14,000 | 69.23% | 0.10% |
| 08/15/2022 | STATE STREET CORP | 13,039 | $4,000 | 0.00% | 0.03% |
| 08/15/2022 | TOWER RESEARCH CAPITAL LLC (TRC) | 4,856 | $2,000 | -75.38% | 0.01% |
| 08/01/2022 | CREATIVE FINANCIAL DESIGNS INC /ADV | 1,075 | $0 | 0.00% | 0.00% |
| 10/27/2022 | MORGAN STANLEY | 300 | $0 | 0.00% | 0.00% |
| 08/12/2022 | WELLS FARGO & COMPANY/MN | 283 | $0 | 8.85% | 0.00% |
| 08/09/2022 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 0.00% |
| 08/12/2022 | RENAISSANCE TECHNOLOGIES LLC | 0 | $0 | -100.00% | 0.00% |
| 08/15/2022 | TWO SIGMA SECURITIES, LLC | 0 | $0 | -100.00% | 0.00% |
| 08/12/2022 | HRT FINANCIAL LP | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 1 institutional investors and hedge funds held shares of Artelo Biosciences, Inc.. The most heavily invested institutionals were:
KEYSTONE WEALTH PARTNERS: 15,000
A. 48.88% of Artelo Biosciences, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 15,000 shares in the last 24 months. This purchase volume represents approximately $20,400 in transactions.
